BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 37004784)

  • 1. Hyaluronic acid-based supramolecular nanomedicine with optimized ratio of oxaliplatin/chlorin e6 for combined chemotherapy and O
    Ding YF; Xu X; Li J; Wang Z; Luo J; Mok GSP; Li S; Wang R
    Acta Biomater; 2023 Jul; 164():397-406. PubMed ID: 37004784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
    Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
    Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted co-delivery of a photosensitizer and an antisense oligonucleotide based on an activatable hyaluronic acid nanosystem with endogenous oxygen generation for enhanced photodynamic therapy of hypoxic tumors.
    Wu Y; Ding L; Zheng C; Li H; Wu M; Sun Y; Liu X; Zhang X; Zeng Y
    Acta Biomater; 2022 Nov; 153():419-430. PubMed ID: 36115655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supramolecular nanomedicine derived from cucurbit[7]uril-conjugated nano-graphene oxide for multi-modality cancer therapy.
    Ding YF; Kwong CHT; Li S; Pan YT; Wei J; Wang LH; Mok GSP; Wang R
    Biomater Sci; 2021 May; 9(10):3804-3813. PubMed ID: 33881050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery and enhanced uptake of chemo-photodynamic nanomedicine for melanoma treatment.
    Huang X; Mu N; Ding Y; Lam HW; Yue L; Gao C; Chen T; Yuan Z; Wang R
    Acta Biomater; 2022 Jul; 147():356-365. PubMed ID: 35577046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor microenvironment-responsive nanohybrid for hypoxia amelioration with photodynamic and near-infrared II photothermal combination therapy.
    Zhang P; Wu Q; Yang J; Hou M; Zheng B; Xu J; Chai Y; Xiong L; Zhang C
    Acta Biomater; 2022 Jul; 146():450-464. PubMed ID: 35526739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
    Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
    Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor.
    Phua SZF; Yang G; Lim WQ; Verma A; Chen H; Thanabalu T; Zhao Y
    ACS Nano; 2019 Apr; 13(4):4742-4751. PubMed ID: 30964974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Delivery Nanomedicine for O
    Zhao LP; Zheng RR; Chen HQ; Liu LS; Zhao XY; Liu HH; Qiu XZ; Yu XY; Cheng H; Li SY
    Nano Lett; 2020 Mar; 20(3):2062-2071. PubMed ID: 32096643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable nanocomplex from hyaluronic acid and arginine based poly(ester amide)s as the delivery vehicles for improved photodynamic therapy of multidrug resistant tumor cells: An in vitro study of the performance of chlorin e6 photosensitizer.
    Ji Y; Zhao J; Chu CC
    J Biomed Mater Res A; 2017 May; 105(5):1487-1499. PubMed ID: 27997760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional theranostic agents based on prussian blue nanoparticles for tumor targeted and MRI-guided photodynamic/photothermal combined treatment.
    Lin X; Cao Y; Xue Y; Wu F; Yu F; Wu M; Zhu X
    Nanotechnology; 2020 Mar; 31(13):135101. PubMed ID: 31783383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme and Reactive Oxygen Species-Responsive Dual-Drug Delivery Nanocomplex for Tumor Chemo-Photodynamic Therapy.
    Xie Q; Gao S; Tian R; Wang G; Qin Z; Chen M; Zhang W; Wen Q; Ma Q; Zhu L
    Int J Nanomedicine; 2023; 18():1-16. PubMed ID: 36632237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
    Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X
    Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 Receptor-Mediated/Reactive Oxygen Species-Sensitive Delivery of Nanophotosensitizers against Cervical Cancer Cells.
    Yoon J; Kim H; Jeong YI; Yang HS
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy.
    Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y
    Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44-mediated tumor homing of hyaluronic acid nanogels for hypoxia-activated photodynamic therapy against tumor.
    Yang HY; Jang MS; Sun XS; Liu CL; Lee JH; Li Y; Fu Y
    Colloids Surf B Biointerfaces; 2023 Aug; 228():113395. PubMed ID: 37327654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells.
    Gaio E; Conte C; Esposito D; Miotto G; Quaglia F; Moret F; Reddi E
    Mol Pharm; 2018 Oct; 15(10):4599-4611. PubMed ID: 30148955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamically assembled nanomedicine based on host-guest molecular recognition for NIR laser-excited chemotherapy and phototheranostics.
    Wu D; Zhang Z; Li X; Zhou J; Cao Y; Qi S; Wang L; Liu Z; Yu G
    Acta Biomater; 2023 Sep; 168():565-579. PubMed ID: 37481192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers.
    Sun CY; Cao Z; Zhang XJ; Sun R; Yu CS; Yang X
    Theranostics; 2018; 8(11):2939-2953. PubMed ID: 29896295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nano-delivery vehicle based on chlorin E6, photodynamic therapy, doxorubicin chemotherapy provides targeted treatment of HER-2 negative, ανβ3-positive breast cancer.
    He Z; Jiang H; Zhang X; Zhang H; Cui Z; Sun L; Li H; Qian J; Ma J; Huang J
    Pharmacol Res; 2020 Oct; 160():105184. PubMed ID: 32946931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.